Open AccessSafety and efficacy of ledipasvir/sofosbuvir on hepatitis C eradication in hepatitis C virus/human immunodeficiency virus co-infected patients
Author(s) -
Xiaoping He,
Lynne Hopkins,
G. Everett,
Willie M Carter,
Cynthia SchroppDyce,
Khalid Abusaada,
Vincent Hsu
Publication year - 2017
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v9.i30.1190
Subject(s) - medicine , ledipasvir , sofosbuvir , hepatitis c , hepatitis c virus , virology , cirrhosis , regimen , ns5a , viral load , gastroenterology , ribavirin , hepacivirus , virus
To evaluate the safety and efficacy of ledipasvir/sofosbuvir on hepatitis C eradication in patients with hepatitis C virus (HCV)/human immunodeficiency virus (HIV) co-infection in an urban HIV clinic.